Stay updated with breaking news from Benefit From. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
First quarter Reported and Adjusted1 Earnings Per Share 2 of 56 cents and 58 cents, an increase of 180% and 45%, respectively, reflects continued strong operational momentum Raised full-year 2024...
Plus, trends that could affect markets in 2024.
Tuesday, Guardant Health Inc (NASDAQ: GH) announced that the FDA's Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee is tentatively scheduled to review the premarket approval application (PMA) for its Shield blood test to screen for colorectal cancer on March 28, 2024. Guardant Health submitted the final module of its PMA for Shield on March 10, 2023. The submission includes data from the ECLIPSE study, an over 20,000-patient registrational study evaluating the perf
Enhanced Cost Structure and Operating Landscape Pave Way for Growth ...
The Green Climate Fund (GCF) has announced the release of USD 100 million at the ongoing United Nations Framework Convention on Climate Change (UNFCCC) 28th Conference of Parties (COP 28) in Dubai, UA